BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 30053598)

  • 1. The prostaglandin EP4 receptor is a master regulator of the expression of PGE
    Kashmiry A; Tate R; Rotondo G; Davidson J; Rotondo D
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Oct; 1863(10):1297-1304. PubMed ID: 30053598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide.
    Bonfill-Teixidor E; Otxoa-de-Amezaga A; Font-Nieves M; Sans-Fons MG; Planas AM
    J Neuroinflammation; 2017 Jan; 14(1):3. PubMed ID: 28086956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binary regulation of interleukin (IL)-6 production by EP1 and EP2/EP4 subtypes of PGE2 receptors in IL-1beta-stimulated human gingival fibroblasts.
    Noguchi K; Shitashige M; Endo H; Kondo H; Ishikawa I
    J Periodontal Res; 2002 Feb; 37(1):29-36. PubMed ID: 11842936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E(2) inhibits IL-18-induced ICAM-1 and B7.2 expression through EP2/EP4 receptors in human peripheral blood mononuclear cells.
    Takahashi HK; Iwagaki H; Yoshino T; Mori S; Morichika T; Itoh H; Yokoyama M; Kubo S; Kondo E; Akagi T; Tanaka N; Nishibori M
    J Immunol; 2002 May; 168(9):4446-54. PubMed ID: 11970988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2 receptors of the EP2 and EP4 subtypes downregulate tumor necrosis factor alpha-induced intercellular adhesion molecule-1 expression in human gingival fibroblasts.
    Noguchi K; Iwasaki K; Shitashige M; Ishikawa I
    J Periodontal Res; 1999 Nov; 34(8):478-85. PubMed ID: 10697805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous prostaglandin E
    Samuchiwal SK; Balestrieri B; Raff H; Boyce JA
    J Biol Chem; 2017 May; 292(20):8195-8206. PubMed ID: 28341741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation.
    Mo C; Zhao R; Vallejo J; Igwe O; Bonewald L; Wetmore L; Brotto M
    Cell Cycle; 2015; 14(10):1507-16. PubMed ID: 25785867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
    Meja KK; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of LPA2R, LPA3R, or EP4R agonists on luteal or endometrial function in vivo or in vitro and sirtuin or EP1R, EP2R, EP3R or EP4R agonists on endometrial secretion of PGE and PGF
    LaPorte ME; Weems YS; Arreguin-Arevalo A; Nett TM; Tsutahara N; Sy T; Haberman J; Chon M; Randel RD; Weems CW
    Theriogenology; 2017 Jun; 95():8-17. PubMed ID: 28460684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PGE
    Neuschäfer-Rube F; Pathe-Neuschäfer-Rube A; Hippenstiel S; Püschel GP
    Cytokine; 2019 Jan; 113():105-116. PubMed ID: 29929938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The EP1/EP3 receptor agonist 17-pt-PGE
    Theiler A; Konya V; Pasterk L; Maric J; Bärnthaler T; Lanz I; Platzer W; Schuligoi R; Heinemann A
    Vascul Pharmacol; 2016 Dec; 87():180-189. PubMed ID: 27664754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
    Kay LJ; Gilbert M; Pullen N; Skerratt S; Farrington J; Seward EP; Peachell PT
    Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PGE2 exerts its effect on the LPS-induced release of TNF-alpha, ET-1, IL-1alpha, IL-6 and IL-10 via the EP2 and EP4 receptor in rat liver macrophages.
    Treffkorn L; Scheibe R; Maruyama T; Dieter P
    Prostaglandins Other Lipid Mediat; 2004 Oct; 74(1-4):113-23. PubMed ID: 15560120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2-dependent prostaglandin E2 down-regulates intercellular adhesion molecule-1 expression via EP2/EP4 receptors in interleukin-1beta-stimulated human gingival fibroblasts.
    Noguchi K; Iwasaki K; Shitashige M; Endo H; Kondo H; Ishikawa I
    J Dent Res; 2000 Dec; 79(12):1955-61. PubMed ID: 11201045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective regulation of RNK-16 cell matrix metalloproteinases by the EP4 subtype of prostaglandin E2 receptor.
    Zeng L; An S; Goetzl EJ
    Biochemistry; 1996 Jun; 35(22):7159-64. PubMed ID: 8679543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of prostaglandin receptors (EPR2-4) in in vivo immunosuppression of PGE2 in rat skin transplant model.
    Fujimoto Y; Iwagaki H; Ozaki M; Ogino T; Murata H; Sun DS; Sadamori H; Takahashi HK; Tanaka N; Yagi T
    Int Immunopharmacol; 2005 Jul; 5(7-8):1131-9. PubMed ID: 15914318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E2 suppresses poly I: C-stimulated cytokine production via EP2 and EP3 in immortalized human corneal epithelial cells.
    Ueta M; Matsuoka T; Sotozono C; Kinoshita S
    Cornea; 2012 Nov; 31(11):1294-8. PubMed ID: 22475642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of the prostaglandin E2-ethanolamide suppression of tumour necrosis factor-α production in human monocytic cells.
    Brown KL; Davidson J; Rotondo D
    Biochim Biophys Acta; 2013 Jun; 1831(6):1098-107. PubMed ID: 23542062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2 Inhibits NLRP3 Inflammasome Activation through EP4 Receptor and Intracellular Cyclic AMP in Human Macrophages.
    Sokolowska M; Chen LY; Liu Y; Martinez-Anton A; Qi HY; Logun C; Alsaaty S; Park YH; Kastner DL; Chae JJ; Shelhamer JH
    J Immunol; 2015 Jun; 194(11):5472-5487. PubMed ID: 25917098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of trophoblast derived prostaglandin E2 receptor 2 (EP2) is reduced in patients with recurrent miscarriage and EP2 regulates cell proliferation and expression of inflammatory cytokines.
    Peng L; Ye Y; Mullikin H; Lin L; Kuhn C; Rahmeh M; Mahner S; Jeschke U; von Schönfeldt V
    J Reprod Immunol; 2020 Nov; 142():103210. PubMed ID: 33011635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.